{"id":7554,"date":"2022-06-01T08:27:04","date_gmt":"2022-06-01T08:27:04","guid":{"rendered":"https:\/\/r-biopharm.com\/?p=7554"},"modified":"2022-06-09T12:26:11","modified_gmt":"2022-06-09T12:26:11","slug":"de-verspreiding-volgen-en-beheersen","status":"publish","type":"post","link":"https:\/\/r-biopharm.com\/nl\/de-verspreiding-volgen-en-beheersen\/","title":{"rendered":"De verspreiding volgen en beheersen"},"content":{"rendered":"<div class=\"wpb-content-wrapper\">[vc_row][vc_column][vc_single_image image=&#8221;7456&#8243; img_size=&#8221;full&#8221; alignment=&#8221;center&#8221;][vc_column_text css=&#8221;.vc_custom_1654777534542{margin-bottom: 0px !important;}&#8221;]Darmstadt, Duitsland, 1 juni 2022 \u2013 R-Biopharm AG, een toonaangevend en wereldwijd opererend biotechnologiebedrijf dat gevestigd is in Duitsland, zal binnenkort een test lanceren voor de detectie van het apenpokkenvirus. De realtime PCR-test, ontwikkeld voor onderzoeksdoeleinden (RUO), zal bijdragen aan het volgen en beheersen van de epidemiologische verspreiding van het virus.<\/p>\n<p>Het product zal naar verwachting over twee tot drie weken beschikbaar zijn onder de naam RIDA\u00aeGENE Monkeypox Virus RUO (onderdeelnummer PG4915RUO). Zoals de test voor de detectie van het SARS-CoV-2-virus, die in februari 2020 als eerste door een Duits bedrijf voor researchdoeleinden werd gelanceerd en in het najaar van 2020 officieel werd goedgekeurd voor de diagnostiek van SARS-CoV-2 met de CE-markering, zal ook de realtime PCR-test voor de detectie van het apenpokkenvirus kunnen worden gebruikt op alle gangbare realtime PCR-instrumenten. Dankzij het uniforme RIDA\u00aeGENE-ontwerp kunnen gebruikers deze test ook samen met andere RIDA\u00aeGENE-producten uitvoeren.<\/p>\n<p>\u201cR-Biopharm geeft om het algemeen welzijn,\u201d zegt Dr. Andreas Simons, hoofd Product Management Clinical Diagnostics bij R-Biopharm. \u201cDaarom zijn we meteen aan de slag gegaan met het ontwerpen van de primers en probes die nodig zijn voor betrouwbare detectie toen het eerste rapport van het Robert Koch Institute kwam van een geval van apenpokken dat geen verband hield met een bezoek aan Afrika.\u201d[\/vc_column_text][\/vc_column][\/vc_row]\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_single_image image=&#8221;7456&#8243; img_size=&#8221;full&#8221; alignment=&#8221;center&#8221;][vc_column_text css=&#8221;.vc_custom_1654777534542{margin-bottom: 0px !important;}&#8221;]Darmstadt, Duitsland, 1 juni 2022 \u2013 R-Biopharm AG, een toonaangevend en wereldwijd opererend biotechnologiebedrijf dat gevestigd is in Duitsland, zal binnenkort een test lanceren voor de detectie van het apenpokkenvirus. De realtime PCR-test, ontwikkeld voor onderzoeksdoeleinden (RUO), zal bijdragen aan het volgen en beheersen van de epidemiologische verspreiding van [&hellip;]<\/p>\n","protected":false},"author":1114,"featured_media":7451,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[358],"tags":[],"class_list":["post-7554","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nieuws-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>De verspreiding volgen en beheersen - R-Biopharm AG<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"De verspreiding volgen en beheersen - R-Biopharm AG\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column][vc_single_image image=&#8221;7456&#8243; img_size=&#8221;full&#8221; alignment=&#8221;center&#8221;][vc_column_text css=&#8221;.vc_custom_1654777534542{margin-bottom: 0px !important;}&#8221;]Darmstadt, Duitsland, 1 juni 2022 \u2013 R-Biopharm AG, een toonaangevend en wereldwijd opererend biotechnologiebedrijf dat gevestigd is in Duitsland, zal binnenkort een test lanceren voor de detectie van het apenpokkenvirus. De realtime PCR-test, ontwikkeld voor onderzoeksdoeleinden (RUO), zal bijdragen aan het volgen en beheersen van de epidemiologische verspreiding van [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/\" \/>\n<meta property=\"og:site_name\" content=\"R-Biopharm AG\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-01T08:27:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-09T12:26:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/r-biopharm.com\/wp-content\/uploads\/220531_rbio_affenpocken_v01_1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1667\" \/>\n\t<meta property=\"og:image:height\" content=\"1667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"niclas\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"niclas\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/\"},\"author\":{\"name\":\"niclas\",\"@id\":\"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4\"},\"headline\":\"De verspreiding volgen en beheersen\",\"datePublished\":\"2022-06-01T08:27:04+00:00\",\"dateModified\":\"2022-06-09T12:26:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/\"},\"wordCount\":242,\"image\":{\"@id\":\"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/r-biopharm.com\/wp-content\/uploads\/220531_rbio_affenpocken_v01_1.jpg\",\"articleSection\":[\"Nieuws\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/\",\"url\":\"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/\",\"name\":\"De verspreiding volgen en beheersen - R-Biopharm AG\",\"isPartOf\":{\"@id\":\"https:\/\/r-biopharm.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/r-biopharm.com\/wp-content\/uploads\/220531_rbio_affenpocken_v01_1.jpg\",\"datePublished\":\"2022-06-01T08:27:04+00:00\",\"dateModified\":\"2022-06-09T12:26:11+00:00\",\"author\":{\"@id\":\"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4\"},\"breadcrumb\":{\"@id\":\"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/#primaryimage\",\"url\":\"https:\/\/r-biopharm.com\/wp-content\/uploads\/220531_rbio_affenpocken_v01_1.jpg\",\"contentUrl\":\"https:\/\/r-biopharm.com\/wp-content\/uploads\/220531_rbio_affenpocken_v01_1.jpg\",\"width\":1667,\"height\":1667},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/r-biopharm.com\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"De verspreiding volgen en beheersen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/r-biopharm.com\/#website\",\"url\":\"https:\/\/r-biopharm.com\/\",\"name\":\"R-Biopharm AG\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/r-biopharm.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4\",\"name\":\"niclas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/r-biopharm.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g\",\"caption\":\"niclas\"},\"url\":\"https:\/\/r-biopharm.com\/nl\/author\/niclas\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"De verspreiding volgen en beheersen - R-Biopharm AG","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/","og_locale":"nl_NL","og_type":"article","og_title":"De verspreiding volgen en beheersen - R-Biopharm AG","og_description":"[vc_row][vc_column][vc_single_image image=&#8221;7456&#8243; img_size=&#8221;full&#8221; alignment=&#8221;center&#8221;][vc_column_text css=&#8221;.vc_custom_1654777534542{margin-bottom: 0px !important;}&#8221;]Darmstadt, Duitsland, 1 juni 2022 \u2013 R-Biopharm AG, een toonaangevend en wereldwijd opererend biotechnologiebedrijf dat gevestigd is in Duitsland, zal binnenkort een test lanceren voor de detectie van het apenpokkenvirus. De realtime PCR-test, ontwikkeld voor onderzoeksdoeleinden (RUO), zal bijdragen aan het volgen en beheersen van de epidemiologische verspreiding van [&hellip;]","og_url":"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/","og_site_name":"R-Biopharm AG","article_published_time":"2022-06-01T08:27:04+00:00","article_modified_time":"2022-06-09T12:26:11+00:00","og_image":[{"width":1667,"height":1667,"url":"https:\/\/r-biopharm.com\/wp-content\/uploads\/220531_rbio_affenpocken_v01_1.jpg","type":"image\/jpeg"}],"author":"niclas","twitter_misc":{"Geschreven door":"niclas","Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/#article","isPartOf":{"@id":"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/"},"author":{"name":"niclas","@id":"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4"},"headline":"De verspreiding volgen en beheersen","datePublished":"2022-06-01T08:27:04+00:00","dateModified":"2022-06-09T12:26:11+00:00","mainEntityOfPage":{"@id":"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/"},"wordCount":242,"image":{"@id":"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/#primaryimage"},"thumbnailUrl":"https:\/\/r-biopharm.com\/wp-content\/uploads\/220531_rbio_affenpocken_v01_1.jpg","articleSection":["Nieuws"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/","url":"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/","name":"De verspreiding volgen en beheersen - R-Biopharm AG","isPartOf":{"@id":"https:\/\/r-biopharm.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/#primaryimage"},"image":{"@id":"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/#primaryimage"},"thumbnailUrl":"https:\/\/r-biopharm.com\/wp-content\/uploads\/220531_rbio_affenpocken_v01_1.jpg","datePublished":"2022-06-01T08:27:04+00:00","dateModified":"2022-06-09T12:26:11+00:00","author":{"@id":"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4"},"breadcrumb":{"@id":"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/#primaryimage","url":"https:\/\/r-biopharm.com\/wp-content\/uploads\/220531_rbio_affenpocken_v01_1.jpg","contentUrl":"https:\/\/r-biopharm.com\/wp-content\/uploads\/220531_rbio_affenpocken_v01_1.jpg","width":1667,"height":1667},{"@type":"BreadcrumbList","@id":"https:\/\/r-biopharm.com\/it\/tracciametracciamento-e-controllo-della-diffusione\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/r-biopharm.com\/nl\/"},{"@type":"ListItem","position":2,"name":"De verspreiding volgen en beheersen"}]},{"@type":"WebSite","@id":"https:\/\/r-biopharm.com\/#website","url":"https:\/\/r-biopharm.com\/","name":"R-Biopharm AG","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/r-biopharm.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Person","@id":"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4","name":"niclas","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/r-biopharm.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g","caption":"niclas"},"url":"https:\/\/r-biopharm.com\/nl\/author\/niclas\/"}]}},"_links":{"self":[{"href":"https:\/\/r-biopharm.com\/nl\/wp-json\/wp\/v2\/posts\/7554","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/r-biopharm.com\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/r-biopharm.com\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/r-biopharm.com\/nl\/wp-json\/wp\/v2\/users\/1114"}],"replies":[{"embeddable":true,"href":"https:\/\/r-biopharm.com\/nl\/wp-json\/wp\/v2\/comments?post=7554"}],"version-history":[{"count":2,"href":"https:\/\/r-biopharm.com\/nl\/wp-json\/wp\/v2\/posts\/7554\/revisions"}],"predecessor-version":[{"id":7556,"href":"https:\/\/r-biopharm.com\/nl\/wp-json\/wp\/v2\/posts\/7554\/revisions\/7556"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/r-biopharm.com\/nl\/wp-json\/wp\/v2\/media\/7451"}],"wp:attachment":[{"href":"https:\/\/r-biopharm.com\/nl\/wp-json\/wp\/v2\/media?parent=7554"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/r-biopharm.com\/nl\/wp-json\/wp\/v2\/categories?post=7554"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/r-biopharm.com\/nl\/wp-json\/wp\/v2\/tags?post=7554"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}